Intrauterine devices in nulliparous women
- PMID: 1776557
- DOI: 10.1007/BF02340179
Intrauterine devices in nulliparous women
Abstract
The majority of studies on the clinical events following the insertion of an intrauterine device for contraception have observed a higher frequency of adverse effects in nulliparous women. In this review, the significance of nulliparity on the occurrence of medical removal for bleeding and pain, expulsion and pelvic inflammatory disease is estimated. The possible role of the anatomy of the pregravid uterus is discussed, and results obtained through a selective measurement of the endometrial cavity in a population of nulligravidas is presented. It is concluded that IUDs should not be the first choice of contraception in nulliparous women because of an increased risk of long-term adverse effects. The relationship between the length of the intrauterine device and the length of the endometrial cavity does not seem to be of clinical significance for the performance of IUDs in nulliparous women.
Similar articles
-
A review of the use of intrauterine devices in nulliparous women.Contraception. 1982 Oct;26(4):323-46. doi: 10.1016/0010-7824(82)90101-9. Contraception. 1982. PMID: 6759026 Review.
-
Factors affecting intrauterine contraceptive device performance. I. Endometrial cavity length.Am J Obstet Gynecol. 1976 Dec 15;126(8):973-81. doi: 10.1016/0002-9378(76)90687-6. Am J Obstet Gynecol. 1976. PMID: 998687
-
Use of intrauterine contraceptive devices in nulliparous women: personal experience over a 12-year period.Eur J Contracept Reprod Health Care. 1998 Dec;3(4):190-3. doi: 10.3109/13625189809167252. Eur J Contracept Reprod Health Care. 1998. PMID: 10036601
-
Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.Hum Reprod. 2015 Jul;30(7):1580-8. doi: 10.1093/humrep/dev102. Epub 2015 May 19. Hum Reprod. 2015. PMID: 25990577
-
Intrauterine contraceptive device and pelvic inflammatory disease.Ann Med. 1993 Apr;25(2):171-3. doi: 10.3109/07853899309164163. Ann Med. 1993. PMID: 8489756 Review.
Cited by
-
Precision intrauterine contraception may significantly increase continuation of use: a review of long-term clinical experience with frameless copper-releasing intrauterine contraception devices.Int J Womens Health. 2013 Apr 30;5:215-25. doi: 10.2147/IJWH.S42784. Print 2013. Int J Womens Health. 2013. PMID: 23658502 Free PMC article.
-
A review of barriers and myths preventing the more widespread use of intrauterine contraception in nulliparous women.Eur J Contracept Reprod Health Care. 2012 Oct;17(5):340-50. doi: 10.3109/13625187.2012.700744. Epub 2012 Jul 26. Eur J Contracept Reprod Health Care. 2012. PMID: 22834648 Free PMC article. Review.
-
New intrauterine technologies for contraception and treatment in -nulliparous/adolescent and parous women.Facts Views Vis Obgyn. 2009;1(3):223-32. Facts Views Vis Obgyn. 2009. PMID: 25489467 Free PMC article.
-
Increasing access to intrauterine contraceptive device uptake in Ghana: stakeholders views on task sharing service delivery with community health nurses.Ghana Med J. 2020 Jun;54(2):114-120. doi: 10.4314/gmj.v54i2.10. Ghana Med J. 2020. PMID: 33536682 Free PMC article.